NPI: 1861469983 · MARIANNA, FL 32448 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/07/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/07/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,385 | $2.51M |
| 2019 | 19,606 | $2.54M |
| 2020 | 24,384 | $3.63M |
| 2021 | 21,415 | $1.54M |
| 2022 | 11,989 | $1.75M |
| 2023 | 5,453 | $492K |
| 2024 | 2,014 | $115K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 29,951 | 1,301 | $3.93M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 33,696 | 2,067 | $3.82M |
| J1270 | Injection, doxercalciferol, 1 mcg | 17,999 | 1,113 | $2.16M |
| A4657 | Syringe, with or without needle, each | 3,418 | 1,411 | $800K |
| J1756 | Injection, iron sucrose, 1 mg | 4,764 | 976 | $508K |
| 82728 | 1,952 | 1,254 | $227K | |
| 83540 | 1,931 | 1,238 | $222K | |
| 83550 | 1,868 | 1,203 | $219K | |
| 85041 | 1,733 | 1,071 | $193K | |
| 83970 | 1,401 | 904 | $193K | |
| 85048 | 1,725 | 1,066 | $193K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 465 | 216 | $61K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 171 | 77 | $42K |
| 90674 | 57 | 42 | $7K | |
| G0008 | Administration of influenza virus vaccine | 92 | 62 | $4K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 23 | 12 | $647.66 |